Mulcan International Investments.

Mulcan International Investments.

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Germany, Munich


The fund is located in Germany, Europe. The primary office of this VC is located in Munich.

The fund usually invests in rounds together with 4-5 others. Besides Mulcan International Investments., start-ups are typically funded by High-Tech Gründerfonds, Bayern Kapital GmbH. The most common co-investors for the fund are Vesalius Biocapital Partners, High-Tech Gründerfonds, Bayern Kapital GmbH.

Mecuris is amongst the various portfolio company of this fund. We can highlight the most popular investment areas for this fund, such as 3D Printing, Manufacturing. In addition, there are 2 more industries where it has achieved success. Moreover, a start-up needs to be 2-3 years old to get investment from this fund. The country of its establishment and the country of its most frequent investments coincides - Germany.

Deals in the range of 1 - 5 millions dollars are most common for this fund. The fund typically enters into 2-6 deals annually. This fund was the most active in 2019.

Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing in Previous

High-Tech Gründerfonds, Bayern Kapital GmbH

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: